Sonata

Product NDC
60793-145
11-digit product format
607930145
Labeler code
60793
Product ID
60793-145_e1f1fb8b-9f7b-4f27-a830-aa049ad07538
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
zaleplon
Dosage form
CAPSULE
Route
ORAL
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
NDA020859
Marketing category
NDA
Marketing start
1999-08-13
Marketing end
0000-00-00
Substance
ZALEPLON
Active strength
5 mg/1
Pharmacologic classes
gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
11ca9bc5-afb0-a2d5-938a-c2d33f89f4abProduct name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60793-145-01EA - Each60793-1453e840b9b-e302-4fa6-9917-7eebc581363a12012-07-24

DailyMed Socrata Ingredients#

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
261286Sonata 10 MG Oral CapsulePSN43ac81cb-1e3f-4d44-86bd-13db2721d0602
261285Sonata 5 MG Oral CapsulePSN43ac81cb-1e3f-4d44-86bd-13db2721d0602
313761zaleplon 10 MG Oral CapsulePSN43ac81cb-1e3f-4d44-86bd-13db2721d0602
313762zaleplon 5 MG Oral CapsulePSN43ac81cb-1e3f-4d44-86bd-13db2721d0602
261286zaleplon 10 MG Oral Capsule [Sonata]SBD43ac81cb-1e3f-4d44-86bd-13db2721d0602
261285zaleplon 5 MG Oral Capsule [Sonata]SBD43ac81cb-1e3f-4d44-86bd-13db2721d0602
313761zaleplon 10 MG Oral CapsuleSCD43ac81cb-1e3f-4d44-86bd-13db2721d0602
313762zaleplon 5 MG Oral CapsuleSCD43ac81cb-1e3f-4d44-86bd-13db2721d0602
261286Sonata 10 MG Oral CapsuleSY43ac81cb-1e3f-4d44-86bd-13db2721d0602
261285Sonata 5 MG Oral CapsuleSY43ac81cb-1e3f-4d44-86bd-13db2721d0602